S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

TEVA Teva Pharmaceutical Industries Ltd

18.00

0.04 (0.22%)

19 Oct 2024 - Closed

Delayed by 15 minutes

Form 144/A - Report of proposed sale of securities: [Amend]

Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From Sep 2024 to Oct 2024

Click Here for more Teva Pharmaceutical Indu... Charts.

Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From Oct 2023 to Oct 2024

Click Here for more Teva Pharmaceutical Indu... Charts.

Teva Pharmaceutical Industries Ltd News

BP Signals Rising Net Debt; Tesla Slumps; Stellantis CEO Announces Retirement; Berkshire Trims BofA Stake, and More
Friday 11 October 2024 (1 week ago) • IH Market News

Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA
Tuesday 8 October 2024 (2 weeks ago) • GlobeNewswire Inc.

Teva and mAbxience Expand Strategic Partnership to include an additional Oncology Biosimilar Candidate
Thursday 3 October 2024 (2 weeks ago) • GlobeNewswire Inc.

Teva Announces Launch of the First and Only Generic Version of Sandostatin® LAR Depot (octreotide acetate for injectable suspension), in the U.S.
Tuesday 1 October 2024 (3 weeks ago) • GlobeNewswire Inc.

Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at 8 a.m. ET on November 6, 2024
Tuesday 1 October 2024 (3 weeks ago) • GlobeNewswire Inc.

Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients with Debilitating Movement Disorder Tardive Dyskinesia
Monday 23 September 2024 (4 weeks ago) • GlobeNewswire Inc.

Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable for Adult Patients Diagnosed with Schizophrenia
Saturday 21 September 2024 (4 weeks ago) • GlobeNewswire Inc.

New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophrenia to UZEDY® (risperidone) Extended-Release Injectable Suspension from Perseris® (RBP-7000)
Saturday 21 September 2024 (4 weeks ago) • GlobeNewswire Inc.

Teva to Present at the Bank of America 2024 Global Healthcare Conference
Thursday 12 September 2024 (1 month ago) • GlobeNewswire Inc.

GameStop plunges 11% on stock offering, DJT drops post-debate, GSK fails shingles vaccine trial
Wednesday 11 September 2024 (1 month ago) • IH Market News

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 4 September 2024 (1 month ago) • Edgar (US Regulatory)

Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
Tuesday 27 August 2024 (2 months ago) • GlobeNewswire Inc.

More Teva Pharmaceutical Industries Ltd News Articles

Bakken Water Transfer Se... (PK)

Brera Tv Nv71 Abs Amort ...

Green Visor Financial Te...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions